Back

Racioethnic Disparities in Risk of Cardiometabolic Risk Factors and Cardiovascular Disease among Women Treated for Breast Cancer: The Pathways Heart Study

Yao, S.; Zimbalist, A.; Sheng, H.; Fiorica, P.; Cheng, R.; Medicino, L.; Omilian, A.; Zhu, Q.; Roh, J.; Laurent, C.; Lee, V.; Ergas, I.; Iribarren, C.; Rana, J.; Nguyen-Huynh, M.; Rillamas-Sun, E.; Hershman, D.; Ambrosone, C.; Kushi, L.; Greenlee, H.; Kwan, M.

2026-04-24 epidemiology
10.64898/2026.04.23.26351612 medRxiv
Show abstract

Racial and ethnic disparities exist in cardiovascular disease (CVD) burden in the general population; yet surprisingly few studies have examined such disparities in breast cancer patients, who are at higher risk due to cardiotoxic therapy. To investigate incidence of CVD and cardiometabolic risk factors across Asian, non-Hispanic Black (NHB), Hispanic, and non-Hispanic White (NHW) women with a history of breast cancer. In 4,071 women with breast cancer from a prospective cohort, the incidence of cardiometabolic risk factors and CVD occurring after breast cancer diagnosis were analyzed with self-identified race and ethnicity (SIRE) and global genetic ancestry. Racial and ethnic differences existed in the prevalence of cardiometabolic risk factors and CVD before breast cancer diagnosis, which continued to manifest in incident cases after cancer treatment. Asian, NHB, and Hispanic women were all at higher risk of diabetes than NHW women. Nonetheless, only NHB women had higher risk of CVD events, and Hispanic women were at lower risk. The apparent lower risk of CVD in Asian women largely disappeared after adjustment for covariates. Similar differences across SIRE groups were found in the cardiotoxic chemotherapy subgroup and the subgroup without chemotherapy, except for any CVD and VTE showing modifying effects of cardiotoxic chemotherapy. Analyses of genetic ancestry revealed similar results to SIRE. Our study reveals racial and ethnic disparities in cardiometabolic risk factors and CVD events before and after breast cancer diagnosis. Clinical and research attention is warranted to bridge the population-level gaps in CVD morbidity and mortality. Statement of SignificanceOur study provides strong evidence for racial and ethnic disparities in cardiovascular disease before and after breast cancer diagnosis. Clinical and research attention is warranted to bridge these population-level gaps.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Journal of the American Heart Association
119 papers in training set
Top 0.2%
18.8%
2
JNCI Cancer Spectrum
10 papers in training set
Top 0.1%
6.9%
3
Cancers
200 papers in training set
Top 1%
4.9%
4
International Journal of Epidemiology
74 papers in training set
Top 0.5%
4.0%
5
Breast Cancer Research
32 papers in training set
Top 0.2%
4.0%
6
Scientific Reports
3102 papers in training set
Top 35%
3.6%
7
PLOS ONE
4510 papers in training set
Top 38%
3.6%
8
Cancer Epidemiology, Biomarkers & Prevention
17 papers in training set
Top 0.2%
3.6%
9
American Journal of Epidemiology
57 papers in training set
Top 0.5%
2.1%
50% of probability mass above
10
Journal of Racial and Ethnic Health Disparities
11 papers in training set
Top 0.1%
2.1%
11
eLife
5422 papers in training set
Top 35%
2.1%
12
Arteriosclerosis, Thrombosis, and Vascular Biology
65 papers in training set
Top 1.0%
1.9%
13
JNCI: Journal of the National Cancer Institute
16 papers in training set
Top 0.3%
1.8%
14
PLOS Medicine
98 papers in training set
Top 2%
1.8%
15
Annals of Oncology
13 papers in training set
Top 0.4%
1.8%
16
Frontiers in Endocrinology
53 papers in training set
Top 1%
1.7%
17
BMJ Open
554 papers in training set
Top 9%
1.7%
18
International Journal of Cancer
42 papers in training set
Top 0.6%
1.7%
19
Circulation
66 papers in training set
Top 2%
1.7%
20
The Journal of Clinical Endocrinology & Metabolism
35 papers in training set
Top 0.7%
1.7%
21
European Journal of Preventive Cardiology
13 papers in training set
Top 0.6%
1.3%
22
JAMA Network Open
127 papers in training set
Top 3%
1.3%
23
Communications Medicine
85 papers in training set
Top 0.5%
1.2%
24
Nutrients
64 papers in training set
Top 1%
1.1%
25
Cancer Medicine
24 papers in training set
Top 1%
1.0%
26
eBioMedicine
130 papers in training set
Top 3%
0.9%
27
Diabetologia
36 papers in training set
Top 0.9%
0.8%
28
Metabolism
14 papers in training set
Top 0.4%
0.8%
29
BMC Medicine
163 papers in training set
Top 6%
0.8%
30
F1000Research
79 papers in training set
Top 4%
0.8%